1. Home
  2. HUMAW vs RTACU Comparison

HUMAW vs RTACU Comparison

Compare HUMAW & RTACU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Humacyte Inc. Warrant

HUMAW

Humacyte Inc. Warrant

HOLD

Current Price

$0.01

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

RTACU

Renatus Tactical Acquisition Corp I Unit

HOLD

Current Price

$11.03

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUMAW
RTACU
Founded
2004
N/A
Country
United States
United States
Employees
184
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
HUMAW
RTACU
Price
$0.01
$11.03
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
34.9K
11.6K
Earning Date
03-21-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.00
$10.40
52 Week High
$0.60
$14.25

Technical Indicators

Market Signals
Indicator
HUMAW
RTACU
Relative Strength Index (RSI) 35.44 68.37
Support Level $0.00 $10.67
Resistance Level $0.12 $11.24
Average True Range (ATR) 0.01 0.10
MACD 0.00 0.02
Stochastic Oscillator 19.90 62.05

Price Performance

Historical Comparison
HUMAW
RTACU

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About RTACU Renatus Tactical Acquisition Corp I Unit

Renatus Tactical Acquisition Corp I is a blank check company.

Share on Social Networks: